Zobrazeno 1 - 10
of 231
pro vyhledávání: '"L. BENEDUCE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
7th Congress of European Microbiologists (FEMS), Valencia, Spain, 9-13 July
info:cnr-pdr/source/autori:C. Berbegal 1, L. Beneduce 2, A. Vernile 2, F. Grieco 3, G. Spano 2, V. Capozzi 2/congresso_nome:7th Congress of European Microbiologists (FEMS)/congresso_luogo:Valencia, Spain/congresso_data:9-13 July/anno:2017/pagina_da:/pagina_a:/intervallo_pagine
info:cnr-pdr/source/autori:C. Berbegal 1, L. Beneduce 2, A. Vernile 2, F. Grieco 3, G. Spano 2, V. Capozzi 2/congresso_nome:7th Congress of European Microbiologists (FEMS)/congresso_luogo:Valencia, Spain/congresso_data:9-13 July/anno:2017/pagina_da:/pagina_a:/intervallo_pagine
Background: The winemaking process includes two key steps performed carried out by microorganisms, i.e. alcoholic fermentation (AF) and malolactic fermentation (MLF). The AF primarily produce the is essential; conversion of grape must sugars from gra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::a9b20063a92327d6fcd58da1b8e5f87a
http://www.cnr.it/prodotto/i/374638
http://www.cnr.it/prodotto/i/374638
Autor:
Roberto Santoro, Giuseppe Maria Ettorre, Pasquale Pierimarchi, Enrico Garaci, Guido Rasi, Claudia Matteucci, Sergio Bernardini, Paolo Casalino, Cesare Sarrecchia, L. Bellis, Giovanni Vennarecci, Daria Scacciatelli, Patrizia Pontisso, Claudio Puoti, Valentina Svicher, Alessandra Biasiolo, R Sorrentino, L. Beneduce
Publikováno v:
Hepatology Research. 44:1008-1018
The identification and surveillance of patients with liver dysfunctions and the discovering of new disease biomarkers are needed in the clinical practice. The aim of this study was to investigate on Survivin-immunoglobulin (Ig)M immune complex (IC) a
Autor:
Paolo Pengo, Andrea Gallotta, Jarinrat Kongkamnerd, Calogero Terregino, Wanchai De-Eknamkul, L. Beneduce, Vladimir Frecer, Stanislav Miertus, Nutthapon Jongaroonngamsang, Adolfo Prandi, Giorgio Fassina, Pornchai Rojsitthisak, Giovanni Cattoli, Ilaria Capua, Luca Cappelletti, Thanyada Rungrotmongkol, Pierfausto Seneci, Adelaide Milani
Publikováno v:
Bioorganic & Medicinal Chemistry. 20:2152-2157
Evidences of oseltamivir resistant influenza patients raised the need of novel neuraminidase inhibitors. In this study, five oseltamivir analogs PMC-31–PMC-36, synthesised according to the outcomes of a rational design analysis aimed to investigate
Autor:
L. Beneduce, Paolo Pengo, Francesca Dinon, Andrea Gallotta, Matteo Salvalaglio, Giorgio Fassina, Carlo Cavallotti
Publikováno v:
Journal of Molecular Recognition. 24:1087-1094
A novel dendrimeric peptide ligand dubbed D-PAM-Φ was designed to achieve a high capacity for human IgG through the decoration of the D-PAM scaffold. The design criteria based on the introduction of small hydrophobic groups on the D-PAM structure we
Autor:
Giovanni Cattoli, Calogero Terregino, Andrea Gallotta, Jarinrat Kongkamnerd, Wanchai De-Eknamkul, Ilaria Capua, L. Beneduce, Paolo Pengo, Adelaide Milani, Stanislav Miertus, Giorgio Fassina
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry. 27:5-11
Development of inexpensive and safe enzymatic assays to screen for putative neuraminidase inhibitors.Validate the use of recombinant neuraminidase expressed in baculovirus located on the viral surface capsule to develop a neuraminidase inhibitor scre
Publikováno v:
SLAS Discovery. 15:1274-1280
formed by immunoglobulins of the M class (IgM) and tumor-associated antigens was recently found in sera of individuals affected by neoplastic diseases such as hepatocellular carcinoma 1-3 and colorectal 4 and prostate cancer 5 in their early stages.
Autor:
M Cnotliwy, A Schmidt, A Badaoui, Alfredo Martinez J, Fabio Penna, C-Y Chang, van der Wal Ac, N-H Lu, SB Felix, K-C Chang, M Lichtenauer, Schwenger, A Cuocolo, O Lukivskaya, C-J Wen, PA Davis, T Reiberger, de Boer Oj, LR Herda, Peter Stenvinkel, CF Ebenbichler, G Ndrepepa, P Starkel, L Spinelli, Y Zhu, HJ Ankersmit, A Kastrati, Cda Stehouwer, M Peck-Radosavljevic, AB Crujeiras, MC Garcia-Gomez, Gyh Lip, M Rodriguez-Moran, S Mueller-Krebs, Petra Luschnig, N Kuzniatsova, X Pinto, A Tschoner, I Wiernicki, S Kaser, WH Hoerl, Y-K Lin, G Fassina, EK Hoogeveen, DG Haider, G Nicolaou, Mauro Maniscalco, C Erridge, LA Calo, Paola Costelli, Juan Jesus Carrero, B Iglseder, Y-J Chen, G Latella, Akos Heinemann, L Beneduce, DL Vesely, F Guerrero-Romero, P Strasser, H Suzuki, K-C Huang, G Zanninelli, Christian Anderwald, VU Buko
Publikováno v:
European Journal of Clinical Investigation. 40:770-789
Autor:
Patrizia Pontisso, Dean Cerin, Andrea Gallotta, Radovan Toth, Angelo Gatta, Vladimir Frecer, Sabrina Meo, Jessica Zuin, Alessandra Biasiolo, Giorgio Fassina, Massimo Gion, Paolo Pengo, N. Tono, L. Beneduce, Gianluca Veggiani
Publikováno v:
cclm. 48:217-223
Background: Squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) is a useful biomarker for the risk of development of hepatocellular carcinoma (HCC) in patients with cirrhosis due to its progressive increase associated to HCC evolution. In pat